Navigation Links
MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
Date:2/28/2011

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that LEVADEX™ orally inhaled migraine therapy will be featured in one oral presentation and four poster presentations at the 63rd Annual Meeting of the American Academy of Neurology (AAN) in Honolulu, Hawaii April 9-16, 2011. A summary of the Company's AAN presentations is below, and the abstracts can be accessed at the AAN website at www.aan.com. LEVADEX is an investigational acute therapy for migraine that has completed Phase 3 clinical development.Utility of LEVADEX (MAP0004) in Situations Where Early Intervention Paradigm Is Impractical Session Info: Platform Session: April 12, 2011, 3:00-4:30 p.m. HASTPresentation Info: April 12, 2011 at 3:45 p.m. HASTPresentation #: 004An Open-Label, 2-Period, Crossover Study Comparing the Pharmacokinetics and Tolerability of LEVADEX (MAP0004, Orally Inhaled DHE) and Intravenous DHE (DHE45®) in Smoking and Non-Smoking Adult VolunteersSession Info: Poster Session 3: April 12, 2011, 2:00-6:00 p.m. HASTPoster #: 028A Randomized, Double-Blind, Placebo Controlled, Three-Period Crossover Study Comparing the Acute Effects of LEVADEX (MAP0004, Orally Inhaled DHE) and Intravenous DHE on Pulmonary Arterial Systolic PressureSession Info: Poster Session 3: April 12, 2011, 2:00-6:30 p.m. HASTPoster #: 029The Major Metabolite of Dihydroergotamine (DHE) after Oral Inhalation and IV Administration Does Not Significantly Contribute to the Pharmacologic ActivitySession Info: Poster Session 5: April 13, 2011, 2:00-6:30 p.m. HASTPoster #: 272Migraine Recurrence Rates: Case for Standardization of the DefinitionSession Info: Poster Session 5: April 13, 2011, 2:00-6:30 p.m. HASTPoster #: 285About LEVADEX™ LEVADEX is an investigational acute therapy for migraine that has completed Phase 3 clinical deve
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
2. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
3. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
5. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
6. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
8. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
9. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
10. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
11. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... HOLBROOK, N.Y. , Dec. 17, 2014 /PRNewswire/ ... that The Depository Trust Company (DTC) has made ... the Deposit Chill on the Company,s stock effective ... of Northstar,s common stock for depository and book ... and the Company is now once again fully ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014 PCCA ... Approved ( http://bit.ly/1382OkS ) program seal for ... community. The program highlights medical practices, materials and ... "autism-community friendly." Children affected by autism ... can be exacerbated by ingredients found in food ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2012 Seventeen Banner Health facilities have achieved Stage ... medical record (EMR) as acknowledged by HIMSS Analytics, a ... Management Systems Society. HIMSS Analytics monitors and recognizes levels ... the United States, Canada and other countries. ...
... (NYSE: WPI ), a leading specialty global pharmaceutical ... Executive Officer, will provide an overview and update of the ... Healthcare Conference on Wednesday, May 16, 2012 at 10:00 AM ... Vegas, Nevada. The presentation will be webcast live and can ...
Cached Medicine Technology:Seventeen Banner Health facilities achieve final stage of electronic medical record adoption 2Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference 2
(Date:12/17/2014)... HeartMath® Inc., recognized as one of ... variability (HRV), heart coherence and the physiology of ... and algorithms to chipset manufacturers and consumer electronics ... to offer its HRV solutions, tap into its ... its normative HRV databases and algorithms for developing ...
(Date:12/17/2014)... December 17, 2014 Project Veritas is ... brought videos of MIT economist and Obamacare architect Jonathan ... James O’Keefe conducted the interview, which is being distributed ... there was intentional mislabeling in the Affordable Care Act ... bill: A two-hundred-and-fifty billion dollar per year tax grab. ...
(Date:12/17/2014)... TUESDAY, Dec. 16, 2014 (HealthDay News) -- Greater participation ... new study finds. Researchers followed kids in the ... to poor children in Los Angeles. Over two ... larger improvements in how the brain processes speech and ... Also, the benefits of active participation in music ...
(Date:12/15/2014)... December 15, 2014 Cancer researchers have ... underlying genetic causes of deadly malignant pleural mesothelioma. Surviving ... on their website. Click here to read it ... of Hawaii Cancer Center, and New York’s Langone Medical ... pleural mesothelioma patients in an effort to pinpoint ...
(Date:12/15/2014)... OutMarket , a provider of marketing ... Cheat Sheets ,” a guide that exposes the insider ... the top ten social media networks. , Social ... engagement, and customer service. It can also increase new ... on new networks and weather constantly changing algorithms, they ...
Breaking Medicine News(10 mins):Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3
... factor in poor sleep, a new survey of more than 150,000 ... a lifetime, with the fewest complaints coming from people in their ... Michael Grandner, PhD, lead author of the study. "These results force ... men and women." The study, appearing in the March ...
... HOUSTON - A drug that relieves the severe symptoms of ... survival of patients with the disease, according to a phase ... New England Journal of Medicine . "The Phase ... for many patients with myelofibrosis and now this phase III ...
... News) -- Strict enforcement of underage drinking laws reduces the ... a new study suggests. State lawmakers have relied heavily ... possession of alcohol under the legal age laws -- to ... information on young people aged 15 to 24 from the ...
... HealthDay Reporter , WEDNESDAY, Feb. 29 (HealthDay News) ... flu and Parkinson,s disease appears to speed recovery in ... Traumatic brain injury (TBI) victims who weren,t fully conscious ... given amantadine hydrochloride. The drug is already given "off-label" ...
... Queen,s obstetrics professor has founded one of the first clinics ... a key opportunity in a woman,s life to focus on ... else is doing this at present," says Graeme Smith, who ... , Pregnancy is a stress test in that it can ...
... 2012)Bacteria live in a state of perpetual warfare, with ... when pathogen, over their infected host. New research suggests ... disease cholera, kills off its microbial rivals by jabbing ... for that defense, called the Type 6 secretion system ...
Cached Medicine News:Health News:Study: Sleep gets better with age, not worse 2Health News:Drug improves survival and quality of life for people with myelofibrosis 2Health News:Drug improves survival and quality of life for people with myelofibrosis 3Health News:Strict Underage Drinking Laws May Deter Delinquency in Teens 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 3Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 4Health News:Cholera's nano-dagger 2Health News:Cholera's nano-dagger 3
... RSV antigen test is a ... the presumptive qualitative detection of ... nasopharyngeal specimens in neonatal and ... minute test has a built-in ...
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Medicine Products: